Safety and durability of mRNA-1273–induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trialResearch in context

Summary: Background: Longitudinal changes in vaccination-induced immune response remain inadequately characterized in adolescents. We present long-term safety, immunogenicity, and COVID-19 incidence following a 2-dose mRNA-1273 100-μg primary series, and immunogenicity following a single dose of mR...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Amparo L. Figueroa, Kashif Ali, Gary Berman, Honghong Zhou, Weiping Deng, Wenqin Xu, Stephanie Lussier, Bethany Girard, Frank J. Dutko, Karen Slobod, Anne Yeakey, Frances Priddy, Jacqueline M. Miller, Rituparna Das
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-08-01
Serija:	EClinicalMedicine
Teme:	Durability Safety Long-term COVID-19 vaccine mRNA vaccine mRNA-1273
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2589537024002992
Oznake:	Označite Brez oznak, prvi označite!